As of Mar 27
| -1.12 / -4.68%|
The 6 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 31.50, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +37.98% increase from the last price of 22.83.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.